NCT06518122View on ClinicalTrials.gov

A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

January 3, 2025

Study Completion Date

January 3, 2025

Conditions
Healthy
Interventions
DRUG

HCP1306

Take it once a day per period.

DRUG

RLD2302

Take it once a day per period.

DRUG

RLD2102

Take it once a day per period

Trial Locations (1)

Unknown

Jeonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY